![Currie Gavin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Currie Gavin
Fundador en Biosceptre (Aust) Pty Ltd. .
Perfil
Currie Gavin is the founder of Biosceptre (Aust) Pty Ltd.
He currently works as a Director at Prescare.
Previously, he worked as the Chief Executive Officer & Director at Biosceptre International Ltd.
Cargos activos de Currie Gavin
Empresas | Cargo | Inicio |
---|---|---|
Biosceptre (Aust) Pty Ltd.
![]() Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Biosceptre (Aust) Pty Ltd. develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company was founded in 2000 and is headquartered in North Ryde, Australia. | Fundador | - |
Prescare
![]() Prescare Miscellaneous Commercial ServicesCommercial Services Prescare provides care services including residential, in-home community care and chaplaincy and pastoral care. It offers residential and dementia care, affordable housing, day therapy centre, respite care and social programs. The company is headquartered in Milton, Australia. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Currie Gavin.
Empresas | Cargo | Fin |
---|---|---|
Biosceptre International Ltd.
![]() Biosceptre International Ltd. BiotechnologyHealth Technology Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Biosceptre (Aust) Pty Ltd.
![]() Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Biosceptre (Aust) Pty Ltd. develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company was founded in 2000 and is headquartered in North Ryde, Australia. | Health Technology |
Prescare
![]() Prescare Miscellaneous Commercial ServicesCommercial Services Prescare provides care services including residential, in-home community care and chaplaincy and pastoral care. It offers residential and dementia care, affordable housing, day therapy centre, respite care and social programs. The company is headquartered in Milton, Australia. | Commercial Services |
Biosceptre International Ltd.
![]() Biosceptre International Ltd. BiotechnologyHealth Technology Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry. | Health Technology |
- Bolsa de valores
- Insiders
- Currie Gavin